Advertisement Research ArticleEndocrinologyNeuroscience Open Access | 10.1172/JCI186652 1 Department of Medicine, Division of Endocrinology, Metabolism and Molecular Medicine, 2 Interdepartmental Neuroscience Graduate Program, and 3 Driskill Graduate Program in Life Sciences, Northwestern University, Chicago, Illinois, USA
Relevant Updates to the Interim Bulk Drug Substances List for 503A Pharmacies 2,4,5,6 For a full list of updates, please download the complete Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act document linked above
LCS3 was submitted to the Developmental Therapeutics Program at the National Cancer Institute for assessment of the NCI-60 cell line panel using an established workflow previously described ( Crystal violet stain Ten thousand cells were seeded in triplicate into 6-well plates and then treated the following day with 0.1% DMSO (Fischer, BP231-100) or 1M LCS3
However, these side effects will create opportunities for new products that address the surprising issues faced by GLP-1 users